Recombinant Human Apolipoprotein A-I/Phospholipids Complex ( DrugBank: Phospholipids )

1 disease

ID	Disease name (Link within this page)	Number of trials
79	Homozygous familial hypercholesterolemia	2

79. Homozygous familial hypercholesterolemia

Clinical trials : 142 / Drugs : 114 - (DrugBank : 29) / Drug target genes : 9 - Drug target pathways : 18

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-003998-28-NL (EUCTR)	28/02/2012	14/11/2011	Effect of CER-001 on blockage of arteries (plaque) in subjects with homozygous familial hypercholest ...	Modifying Orphan Disease Evaluation (MODE) Study: A Multicenter, Open-Label Study of the Effects of ...	homozygous familial hypercholesterolemia MedDRA version: 16.0;Level: LLT;Classification code 1002060 ...	Product Name: Recombinant Human Apolipoprotein A-I/Phospholipids Complex Product Code: CER-001 Other d ...	Cerenis Therapeutics	NULL	Not Recruiting			Female: yes Male: yes	30		France;United States;Canada;Netherlands;Italy;United Kingdom
2	EUCTR2011-003998-28-GB (EUCTR)	24/01/2012	19/10/2011	Effect of CER-001 on blockage of arteries (plaque) in subjects with homozygous familial hypercholest ...	Modifying Orphan Disease Evaluation (MODE) Study: A Multicenter, Open-Label Study of the Effects of ...	homozygous familial hypercholesterolemia MedDRA version: 15.0;Level: LLT;Classification code 1002060 ...	Product Name: Recombinant Human Apolipoprotein A-I/Phospholipids Complex Product Code: CER-001 INN or ...	Cerenis Therapeutics	NULL	Not Recruiting			Female: yes Male: yes	30	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Canada;Netherlands;Italy;United Kingdom

First Previous1Next Last